Skip to main content
Erschienen in: Basic Research in Cardiology 5/2016

01.09.2016 | Original Contribution

Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure

verfasst von: Wei Deng, Andrew R. Ednie, Jianyong Qi, Eric S. Bennett

Erschienen in: Basic Research in Cardiology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Dilated cardiomyopathy (DCM), the third most common cause of heart failure, is often associated with arrhythmias and sudden cardiac death if not controlled. The majority of DCM is of unknown etiology. Protein sialylation is altered in human DCM, with responsible mechanisms not yet described. Here we sought to investigate the impact of clinically relevant changes in sialylation on cardiac function using a novel model for altered glycoprotein sialylation that leads to DCM and to chronic stress-induced heart failure (HF), deletion of the sialyltransferase, ST3Gal4. We previously reported that 12- to 20-week-old ST3Gal4 / mice showed aberrant cardiac voltage-gated ion channel sialylation and gating that contribute to a pro-arrhythmogenic phenotype. Here, echocardiography supported by histology revealed modest dilated and thinner-walled left ventricles without increased fibrosis in ST3Gal4 / mice starting at 1 year of age. Cardiac calcineurin expression in younger (16–20 weeks old) ST3Gal4 / hearts was significantly reduced compared to WT. Transverse aortic constriction (TAC) was used as a chronic stressor on the younger mice to determine whether the ability to compensate against a pathologic insult is compromised in the ST3Gal4 / heart, as suggested by previous reports describing the functional implications of reduced cardiac calcineurin levels. TAC’d ST3Gal4 / mice presented with significantly reduced systolic function and ventricular dilation that deteriorated into congestive HF within 6 weeks post-surgery, while constricted WT hearts remained well-adapted throughout (ejection fraction, ST3Gal4 / = 34 ± 5.2 %; WT = 53.8 ± 7.4 %; p < 0.05). Thus, a novel, sialo-dependent model for DCM/HF is described in which clinically relevant reduced sialylation results in increased arrhythmogenicity and reduced cardiac calcineurin levels that precede cardiomyopathy and TAC-induced HF, suggesting a causal link among aberrant sialylation, chronic arrhythmia, reduced calcineurin levels, DCM in the absence of a pathologic stimulus, and stress-induced HF.
Literatur
6.
Zurück zum Zitat Born GV, Palinski W (1985) Unusually high concentrations of sialic acids on the surface of vascular endothelia. Br J Exp Pathol 66:543–549PubMedPubMedCentral Born GV, Palinski W (1985) Unusually high concentrations of sialic acids on the surface of vascular endothelia. Br J Exp Pathol 66:543–549PubMedPubMedCentral
7.
Zurück zum Zitat Brooks S, Hall DS (2012) Lectin histochemistry to detect altered glycosylation in cells and tissues. In: Dwek M, Brooks SA, Schumacher U (eds) Metastasis research protocols. Humana Press, Totowa, pp 31–50CrossRef Brooks S, Hall DS (2012) Lectin histochemistry to detect altered glycosylation in cells and tissues. In: Dwek M, Brooks SA, Schumacher U (eds) Metastasis research protocols. Humana Press, Totowa, pp 31–50CrossRef
8.
Zurück zum Zitat Brooks SA, Leathem AJC, Schumacher U, Society RM (1997) Lectin histochemistry: a concise practical handbook. BIOS Scientific, Oxford Brooks SA, Leathem AJC, Schumacher U, Society RM (1997) Lectin histochemistry: a concise practical handbook. BIOS Scientific, Oxford
9.
Zurück zum Zitat Bueno OF, Lips DJ, Kaiser RA, Wilkins BJ, Dai YS, Glascock BJ, Klevitsky R, Hewett TE, Kimball TR, Aronow BJ, Doevendans PA, Molkentin JD (2004) Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction. Circ Res 94:91–99. doi:10.1161/01.RES.0000107197.99679.77 CrossRefPubMed Bueno OF, Lips DJ, Kaiser RA, Wilkins BJ, Dai YS, Glascock BJ, Klevitsky R, Hewett TE, Kimball TR, Aronow BJ, Doevendans PA, Molkentin JD (2004) Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction. Circ Res 94:91–99. doi:10.​1161/​01.​RES.​0000107197.​99679.​77 CrossRefPubMed
13.
Zurück zum Zitat Camacho Londono JE, Tian Q, Hammer K, Schroder L, Camacho Londono J, Reil JC, He T, Oberhofer M, Mannebach S, Mathar I, Philipp SE, Tabellion W, Schweda F, Dietrich A, Kaestner L, Laufs U, Birnbaumer L, Flockerzi V, Freichel M, Lipp P (2015) A background Ca2 + entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling. Eur Heart J 36:2257–2266. doi:10.1093/eurheartj/ehv250 CrossRefPubMedPubMedCentral Camacho Londono JE, Tian Q, Hammer K, Schroder L, Camacho Londono J, Reil JC, He T, Oberhofer M, Mannebach S, Mathar I, Philipp SE, Tabellion W, Schweda F, Dietrich A, Kaestner L, Laufs U, Birnbaumer L, Flockerzi V, Freichel M, Lipp P (2015) A background Ca2 + entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling. Eur Heart J 36:2257–2266. doi:10.​1093/​eurheartj/​ehv250 CrossRefPubMedPubMedCentral
14.
15.
16.
Zurück zum Zitat Du D, Yang H, Yang H, Ednie A, Bennett E (2015) Statistical Metamodeling and Sequential Design of Computer Experiments to Model Glyco-altered Gating of Sodium Channels in Cardiac Myocytes. IEEE J Biomed Health Inform PP:1 doi:10.1109/JBHI.2015.2458791 Du D, Yang H, Yang H, Ednie A, Bennett E (2015) Statistical Metamodeling and Sequential Design of Computer Experiments to Model Glyco-altered Gating of Sodium Channels in Cardiac Myocytes. IEEE J Biomed Health Inform PP:1 doi:10.​1109/​JBHI.​2015.​2458791
19.
20.
Zurück zum Zitat Ellies LG, Ditto D, Levy GG, Wahrenbrock M, Ginsburg D, Varki A, Le DT, Marth JD (2002) Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci USA 99:10042–10047. doi:10.1073/pnas.142005099 CrossRefPubMedPubMedCentral Ellies LG, Ditto D, Levy GG, Wahrenbrock M, Ginsburg D, Varki A, Le DT, Marth JD (2002) Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci USA 99:10042–10047. doi:10.​1073/​pnas.​142005099 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276. doi:10.1093/eurheartj/ehm342 CrossRefPubMed Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276. doi:10.​1093/​eurheartj/​ehm342 CrossRefPubMed
22.
Zurück zum Zitat Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084. doi:10.1056/NEJM200004133421502 CrossRefPubMed Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084. doi:10.​1056/​NEJM200004133421​502 CrossRefPubMed
23.
Zurück zum Zitat Footitt EJ, Karimova A, Burch M, Yayeh T, Dupre T, Vuillaumier-Barrot S, Chantret I, Moore SE, Seta N, Grunewald S (2009) Cardiomyopathy in the congenital disorders of glycosylation (CDG): a case of late presentation and literature review. J Inherit Metab Dis 32(Suppl 1):S313–S319. doi:10.1007/s10545-009-1262-1 CrossRefPubMed Footitt EJ, Karimova A, Burch M, Yayeh T, Dupre T, Vuillaumier-Barrot S, Chantret I, Moore SE, Seta N, Grunewald S (2009) Cardiomyopathy in the congenital disorders of glycosylation (CDG): a case of late presentation and literature review. J Inherit Metab Dis 32(Suppl 1):S313–S319. doi:10.​1007/​s10545-009-1262-1 CrossRefPubMed
26.
Zurück zum Zitat Ge J, Sun A, Paajanen V, Wang S, Su C, Yang Z, Li Y, Wang S, Jia J, Wang K, Zou Y, Gao L, Wang K, Fan Z (2008) Molecular and clinical characterization of a novel SCN5A mutation associated with atrioventricular block and dilated cardiomyopathy. Circ Arrhythm Electrophysiol 1:83–92. doi:10.1161/CIRCEP.107.750752 CrossRefPubMed Ge J, Sun A, Paajanen V, Wang S, Su C, Yang Z, Li Y, Wang S, Jia J, Wang K, Zou Y, Gao L, Wang K, Fan Z (2008) Molecular and clinical characterization of a novel SCN5A mutation associated with atrioventricular block and dilated cardiomyopathy. Circ Arrhythm Electrophysiol 1:83–92. doi:10.​1161/​CIRCEP.​107.​750752 CrossRefPubMed
27.
Zurück zum Zitat Gehrmann J, Sohlbach K, Linnebank M, Bohles HJ, Buderus S, Kehl HG, Vogt J, Harms E, Marquardt T (2003) Cardiomyopathy in congenital disorders of glycosylation. Cardiol Young 13:345–351. doi:10.1017/S1047951103000702 PubMed Gehrmann J, Sohlbach K, Linnebank M, Bohles HJ, Buderus S, Kehl HG, Vogt J, Harms E, Marquardt T (2003) Cardiomyopathy in congenital disorders of glycosylation. Cardiol Young 13:345–351. doi:10.​1017/​S104795110300070​2 PubMed
29.
Zurück zum Zitat Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics C, Stroke Statistics S (2013) Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127:e6–e245. doi:10.1161/CIR.0b013e31828124ad CrossRefPubMed Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics C, Stroke Statistics S (2013) Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127:e6–e245. doi:10.​1161/​CIR.​0b013e31828124ad​ CrossRefPubMed
32.
Zurück zum Zitat Hu P, Zhang D, Swenson L, Chakrabarti G, Abel ED, Litwin SE (2003) Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 285:H1261–H1269. doi:10.1152/ajpheart.00108.2003 CrossRefPubMed Hu P, Zhang D, Swenson L, Chakrabarti G, Abel ED, Litwin SE (2003) Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 285:H1261–H1269. doi:10.​1152/​ajpheart.​00108.​2003 CrossRefPubMed
35.
36.
Zurück zum Zitat Knezevic A, Polasek O, Gornik O, Rudan I, Campbell H, Hayward C, Wright A, Kolcic I, O’Donoghue N, Bones J, Rudd PM, Lauc G (2009) Variability, heritability and environmental determinants of human plasma N-glycome. J Proteome Res 8:694–701. doi:10.1021/pr800737u CrossRefPubMed Knezevic A, Polasek O, Gornik O, Rudan I, Campbell H, Hayward C, Wright A, Kolcic I, O’Donoghue N, Bones J, Rudd PM, Lauc G (2009) Variability, heritability and environmental determinants of human plasma N-glycome. J Proteome Res 8:694–701. doi:10.​1021/​pr800737u CrossRefPubMed
37.
Zurück zum Zitat Kono M, Ohyama Y, Lee YC, Hamamoto T, Kojima N, Tsuji S (1997) Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression. Glycobiology 7:469–479. doi:10.1093/glycob/7.4.469 CrossRefPubMed Kono M, Ohyama Y, Lee YC, Hamamoto T, Kojima N, Tsuji S (1997) Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression. Glycobiology 7:469–479. doi:10.​1093/​glycob/​7.​4.​469 CrossRefPubMed
38.
Zurück zum Zitat Kranz C, Basinger AA, Gucsavas-Calikoglu M, Sun L, Powell CM, Henderson FW, Aylsworth AS, Freeze HH (2007) Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality. Am J Med Genet A 143A:1371–1378. doi:10.1002/ajmg.a.31791 CrossRefPubMed Kranz C, Basinger AA, Gucsavas-Calikoglu M, Sun L, Powell CM, Henderson FW, Aylsworth AS, Freeze HH (2007) Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality. Am J Med Genet A 143A:1371–1378. doi:10.​1002/​ajmg.​a.​31791 CrossRefPubMed
39.
Zurück zum Zitat Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, Patterson C (2004) Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114:1058–1071. doi:10.1172/JCI22220 CrossRefPubMedPubMedCentral Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, Patterson C (2004) Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114:1058–1071. doi:10.​1172/​JCI22220 CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Mann SA, Castro ML, Ohanian M, Guo G, Zodgekar P, Sheu A, Stockhammer K, Thompson T, Playford D, Subbiah R, Kuchar D, Aggarwal A, Vandenberg JI, Fatkin D (2012) R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy. J Am Coll Cardiol 60:1566–1573. doi:10.1016/j.jacc.2012.05.050 CrossRefPubMed Mann SA, Castro ML, Ohanian M, Guo G, Zodgekar P, Sheu A, Stockhammer K, Thompson T, Playford D, Subbiah R, Kuchar D, Aggarwal A, Vandenberg JI, Fatkin D (2012) R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy. J Am Coll Cardiol 60:1566–1573. doi:10.​1016/​j.​jacc.​2012.​05.​050 CrossRefPubMed
42.
Zurück zum Zitat McNair WP, Sinagra G, Taylor MR, Di Lenarda A, Ferguson DA, Salcedo EE, Slavov D, Zhu X, Caldwell JH, Mestroni L, Familial Cardiomyopathy Registry Research G (2011) SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. J Am Coll Cardiol 57:2160–2168. doi:10.1016/j.jacc.2010.09.084 CrossRefPubMed McNair WP, Sinagra G, Taylor MR, Di Lenarda A, Ferguson DA, Salcedo EE, Slavov D, Zhu X, Caldwell JH, Mestroni L, Familial Cardiomyopathy Registry Research G (2011) SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. J Am Coll Cardiol 57:2160–2168. doi:10.​1016/​j.​jacc.​2010.​09.​084 CrossRefPubMed
45.
Zurück zum Zitat Montpetit ML, Stocker PJ, Schwetz TA, Harper JM, Norring SA, Schaffer L, North SJ, Jang-Lee J, Gilmartin T, Head SR, Haslam SM, Dell A, Marth JD, Bennett ES (2009) Regulated and aberrant glycosylation modulate cardiac electrical signaling. Proc Natl Acad Sci USA 106:16517–16522. doi:10.1073/pnas.0905414106 CrossRefPubMedPubMedCentral Montpetit ML, Stocker PJ, Schwetz TA, Harper JM, Norring SA, Schaffer L, North SJ, Jang-Lee J, Gilmartin T, Head SR, Haslam SM, Dell A, Marth JD, Bennett ES (2009) Regulated and aberrant glycosylation modulate cardiac electrical signaling. Proc Natl Acad Sci USA 106:16517–16522. doi:10.​1073/​pnas.​0905414106 CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Nakayama H, Wilkin BJ, Bodi I, Molkentin JD (2006) Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J: Off Public Fed Am Soc Exp Biol 20:1660–1670. doi:10.1096/fj.05-5560com CrossRef Nakayama H, Wilkin BJ, Bodi I, Molkentin JD (2006) Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J: Off Public Fed Am Soc Exp Biol 20:1660–1670. doi:10.​1096/​fj.​05-5560com CrossRef
47.
Zurück zum Zitat Nanka O, Peumans WJ, Van Damme EJ, Pfuller U, Valasek P, Halata Z, Schumacher U, Grim M (2001) Lectin histochemistry of microvascular endothelium in chick and quail musculature. Anat Embryol (Berl) 204:407–411. doi:10.1007/s004290100212 CrossRef Nanka O, Peumans WJ, Van Damme EJ, Pfuller U, Valasek P, Halata Z, Schumacher U, Grim M (2001) Lectin histochemistry of microvascular endothelium in chick and quail musculature. Anat Embryol (Berl) 204:407–411. doi:10.​1007/​s004290100212 CrossRef
50.
Zurück zum Zitat Okumura T, Murohara T (2013) Contractile reserve in dilated cardiomyopathy. In: José Milei GA (ed) Cardiomyopathies. InTech, pp 47–59. doi:10.5772/55413 Okumura T, Murohara T (2013) Contractile reserve in dilated cardiomyopathy. In: José Milei GA (ed) Cardiomyopathies. InTech, pp 47–59. doi:10.​5772/​55413
52.
Zurück zum Zitat Schaeffer PJ, Desantiago J, Yang J, Flagg TP, Kovacs A, Weinheimer CJ, Courtois M, Leone TC, Nichols CG, Bers DM, Kelly DP (2009) Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice. Am J Physiol Heart Circ Physiol 297:H1263–H1273. doi:10.1152/ajpheart.00152.2009 CrossRefPubMedPubMedCentral Schaeffer PJ, Desantiago J, Yang J, Flagg TP, Kovacs A, Weinheimer CJ, Courtois M, Leone TC, Nichols CG, Bers DM, Kelly DP (2009) Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice. Am J Physiol Heart Circ Physiol 297:H1263–H1273. doi:10.​1152/​ajpheart.​00152.​2009 CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Sperandio M, Frommhold D, Babushkina I, Ellies LG, Olson TS, Smith ML, Fritzsching B, Pauly E, Smith DF, Nobiling R, Linderkamp O, Marth JD, Ley K (2006) Alpha 2,3-sialyltransferase-IV is essential for L-selectin ligand function in inflammation. Eur J Immunol 36:3207–3215. doi:10.1002/eji.200636157 CrossRefPubMed Sperandio M, Frommhold D, Babushkina I, Ellies LG, Olson TS, Smith ML, Fritzsching B, Pauly E, Smith DF, Nobiling R, Linderkamp O, Marth JD, Ley K (2006) Alpha 2,3-sialyltransferase-IV is essential for L-selectin ligand function in inflammation. Eur J Immunol 36:3207–3215. doi:10.​1002/​eji.​200636157 CrossRefPubMed
58.
Zurück zum Zitat Tang M, Li J, Huang W, Su H, Liang Q, Tian Z, Horak KM, Molkentin JD, Wang X (2010) Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. Cardiovasc Res 88:424–433. doi:10.1093/cvr/cvq217 CrossRefPubMedPubMedCentral Tang M, Li J, Huang W, Su H, Liang Q, Tian Z, Horak KM, Molkentin JD, Wang X (2010) Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. Cardiovasc Res 88:424–433. doi:10.​1093/​cvr/​cvq217 CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Ufret-Vincenty CA, Baro DJ, Lederer WJ, Rockman HA, Quinones LE, Santana LF (2001) Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure. J Biol Chem 276:28197–28203. doi:10.1074/jbc.M102548200 CrossRefPubMed Ufret-Vincenty CA, Baro DJ, Lederer WJ, Rockman HA, Quinones LE, Santana LF (2001) Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure. J Biol Chem 276:28197–28203. doi:10.​1074/​jbc.​M102548200 CrossRefPubMed
61.
Zurück zum Zitat Verma SK, Krishnamurthy P, Kishore R (2014) Transverse aortic constriction: a model to study heart failure in small animals. In: Ardehali H, Bolli R, Losordo DW (eds) Manual of research techniques in cardiovascular medicine. Wiley, Oxford, UK. doi:10.1002/9781118495148.ch20 Verma SK, Krishnamurthy P, Kishore R (2014) Transverse aortic constriction: a model to study heart failure in small animals. In: Ardehali H, Bolli R, Losordo DW (eds) Manual of research techniques in cardiovascular medicine. Wiley, Oxford, UK. doi:10.​1002/​9781118495148.​ch20
63.
Zurück zum Zitat Wan E, Abrams J, Weinberg RL, Katchman AN, Bayne J, Zakharov SI, Yang L, Morrow JP, Garan H, Marx SO (2016) Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice. J Clin Invest 126:112–122. doi:10.1172/JCI84669 CrossRefPubMed Wan E, Abrams J, Weinberg RL, Katchman AN, Bayne J, Zakharov SI, Yang L, Morrow JP, Garan H, Marx SO (2016) Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice. J Clin Invest 126:112–122. doi:10.​1172/​JCI84669 CrossRefPubMed
64.
Zurück zum Zitat Waszkiewicz N, Szajda SD, Zalewska A, Szulc A, Kepka A, Minarowska A, Wojewodzka-Zelezniakowicz M, Konarzewska B, Chojnowska S, Ladny JR, Zwierz K (2012) Alcohol abuse and glycoconjugate metabolism. Folia Histochem Cytobiol 50:1–11. doi:10.2478/18690 CrossRefPubMed Waszkiewicz N, Szajda SD, Zalewska A, Szulc A, Kepka A, Minarowska A, Wojewodzka-Zelezniakowicz M, Konarzewska B, Chojnowska S, Ladny JR, Zwierz K (2012) Alcohol abuse and glycoconjugate metabolism. Folia Histochem Cytobiol 50:1–11. doi:10.​2478/​18690 CrossRefPubMed
65.
Zurück zum Zitat Watanabe H, Yang T, Stroud DM, Lowe JS, Harris L, Atack TC, Wang DW, Hipkens SB, Leake B, Hall L, Kupershmidt S, Chopra N, Magnuson MA, Tanabe N, Knollmann BC, George AL Jr, Roden DM (2011) Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation 124:1001–1011. doi:10.1161/CIRCULATIONAHA.110.987248 CrossRefPubMedPubMedCentral Watanabe H, Yang T, Stroud DM, Lowe JS, Harris L, Atack TC, Wang DW, Hipkens SB, Leake B, Hall L, Kupershmidt S, Chopra N, Magnuson MA, Tanabe N, Knollmann BC, George AL Jr, Roden DM (2011) Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation 124:1001–1011. doi:10.​1161/​CIRCULATIONAHA.​110.​987248 CrossRefPubMedPubMedCentral
68.
Zurück zum Zitat Wu AM, Wu JH, Tsai MS, Yang Z, Sharon N, Herp A (2007) Differential affinities of Erythrina cristagalli lectin (ECL) toward monosaccharides and polyvalent mammalian structural units. Glycoconj J 24:591–604. doi:10.1007/s10719-007-9063-y CrossRefPubMed Wu AM, Wu JH, Tsai MS, Yang Z, Sharon N, Herp A (2007) Differential affinities of Erythrina cristagalli lectin (ECL) toward monosaccharides and polyvalent mammalian structural units. Glycoconj J 24:591–604. doi:10.​1007/​s10719-007-9063-y CrossRefPubMed
70.
Zurück zum Zitat Zou Y, Hiroi Y, Uozumi H, Takimoto E, Toko H, Zhu W, Kudoh S, Mizukami M, Shimoyama M, Shibasaki F, Nagai R, Yazaki Y, Komuro I (2001) Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy. Circulation 104:97–101. doi:10.1161/01.CIR.104.1.97 CrossRefPubMed Zou Y, Hiroi Y, Uozumi H, Takimoto E, Toko H, Zhu W, Kudoh S, Mizukami M, Shimoyama M, Shibasaki F, Nagai R, Yazaki Y, Komuro I (2001) Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy. Circulation 104:97–101. doi:10.​1161/​01.​CIR.​104.​1.​97 CrossRefPubMed
Metadaten
Titel
Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure
verfasst von
Wei Deng
Andrew R. Ednie
Jianyong Qi
Eric S. Bennett
Publikationsdatum
01.09.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Basic Research in Cardiology / Ausgabe 5/2016
Print ISSN: 0300-8428
Elektronische ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-016-0574-1

Weitere Artikel der Ausgabe 5/2016

Basic Research in Cardiology 5/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.